For patients with polymyalgia rheumatica with relapse during tapering of glucocorticoid therapy, treatment with sarilumab, the human monoclonal antibody that binds to the interleukin-6 receptor α, is efficacious for achieving ...
Oct 5, 2023
0
1
A lifestyle-based treatment intervention promoting adherence to a whole-food, plant-predominant eating pattern and integrated into routine care can successfully achieve type 2 diabetes remission, according to a research study ...
Jun 21, 2023
0
16
For patients with adenomyosis, mifepristone is efficacious and has acceptable tolerability, according to a study published online June 12 in JAMA Network Open.
Jun 14, 2023
0
2
An improvement in glucose levels, reaching a normal range, and cessation in the need for medication can occur in some patients diagnosed with type 2 diabetes who are provided with lifestyle therapy, temporary pharmacotherapy, ...
Jun 14, 2023
0
5
For patients with moderate-to-severe Crohn disease, upadacitinib induction and maintenance treatment are superior to placebo, according to a study published in the May 25 issue of the New England Journal of Medicine.
May 31, 2023
0
6
New findings have revealed that nearly a quarter (23%) of participants who were in remission from type 2 diabetes at two years in a clinical trial remained in remission at five years.
Apr 19, 2023
0
18
A large study of women with rheumatoid arthritis has found that those taking oral contraceptives or hormone replacement therapy (HRT) had a greater chance of achieving remission.
Mar 16, 2023
0
23
A study led by researchers from IGTP's Immunology of Diabetes group has identified new microRNA as biomarkers for the partial remission phase, also known as "honeymoon phase," of type 1 diabetes, and has linked the miR-30d-5p ...
Mar 6, 2023
0
14
Late-breaking research reveals a major treatment advance for adults with newly diagnosed B lineage acute lymphoblastic leukemia (ALL). The randomized phase 3 study E1910 evaluated blinatumomab immunotherapy in patients with ...
Dec 13, 2022
0
3
A financial assistance program (FAP) improves outcomes for indigent patients with inflammatory bowel disease (IBD), according to a study recently published in Pathophysiology.
Dec 12, 2022
0
20
